Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Filapixant (BAY1902607) with Itraconazole in Healthy Men
NCT03789890Phase 1Completed
- Sponsor
- Bayer
- Start
- Jan 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of filapixant in endometriosis, sponsored by Bayer. Primary endpoints: Maximum Plasma Concentration (Cmax) of BAY1902607 at 96 hours, Maximum Plasma Concentration (Cmax) of BAY1902607 with Itraconazole at 264 hours and 2 more. Started Jan 2019; status: completed.
02
Drugs
filapixant
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03789890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789890.